Rani Therapeutics Ownership | Who Owns Rani Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Rani Therapeutics Ownership Summary


Rani Therapeutics is owned by 11.03% institutional investors, 5.90% insiders, and 83.07% retail investors. Vanguard group is the largest institutional shareholder, holding 2.42% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.29% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRani Therapeutics11.03%5.90%83.07%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group884.61K2.42%$442.31K
Nan fung group493.58K1.35%$246.69K
United services automobile association302.74K0.83%$151.31K
Geode capital management296.91K0.81%$148.41K
Kestra private wealth services226.14K0.62%$113.03K
Takeda pharmaceutical203.19K0.56%$101.55K
Cwa asset management group150.00K0.41%$74.97K
Bank of america corp /de/91.85K0.35%$349.01K
Blackrock funding, inc. /de120.23K0.33%$60.09K
Hrt financial lp113.21K0.31%$56.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical203.19K0.62%$101.55K
Nan fung group493.58K0.41%$246.69K
Lasry marc62.89K0.21%$31.43K
United services automobile association302.74K0.01%$151.31K
Well done52.01K0.00%$26.00K
Act advisors, llc.14.81K0.00%$7.40K
Cwa asset management group150.00K0.00%$74.97K
Islay capital management9.61K0.00%$4.80K
Motco48.13K0.00%$24.05K
Lafayette investments19.89K0.00%$9.94K

Top Buyers

HolderShares% AssetsChange
Hrt financial lp113.21K0.00%113.21K
Geode capital management296.91K-106.35K
Vanguard group884.61K-84.93K
Kestra private wealth services226.14K0.00%70.00K
Cwa asset management group150.00K0.00%66.67K

Top Sellers

HolderShares% AssetsChange
Armistice capital---3.15M
Alphabet---448.49K
Two sigma investments, lp---291.38K
Two sigma advisers, lp---110.16K
Bridgeway capital management---46.50K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp113.21K0.00%113.21K$56.00K
Renaissance24.91K-24.91K$12.45K
Act advisors, llc.14.81K0.00%14.81K$7.40K
Eversource wealth advisors980.00-980.00$490.00
Alphamark advisors500.000.00%500.00$1.00K

Sold Out

HolderChange
Qube research-3.00
Wells fargo & company/mn-103.00
Ameritas advisory services-280.00
Citigroup-313.00
Belvedere trading-991.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202535-5.41%4,030,094-36.17%113.69%1440.00%5-28.57%
Jun 30, 202540-6,453,46589.46%1717.02%10-23.08%1066.67%
Mar 31, 202541-6.82%3,609,389-5.48%106.16%13-38.10%620.00%
Dec 31, 20244433.33%3,818,467-35.40%133.15%2161.54%5-
Sep 30, 202432-11.11%5,707,88197.28%1916.03%138.33%4-42.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv507.61K1.29%-11.09K
Vanguard Institutional Extnd Mkt Idx Tr180.55K0.46%-82.27K
Tema Obesity & Cardiometabolic ETF105.60K0.32%-
Fidelity Extended Market Index96.55K0.20%-680.00
Bridgeway Ultra-Small Company Market46.50K0.12%-
iShares Micro-Cap ETF50.13K0.10%-
Spartan Extended Market Index Pool E22.45K0.07%7.55K
Fidelity Series Total Market Index26.83K0.06%-
BlackRock Extended Equity Market K16.40K0.06%-7.00
Fidelity Total Market Index26.09K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 23, 2025IMRAN MIR A Buy$1.26M
Oct 23, 2025IMRAN MIR A Buy$1.00M
Oct 20, 2025South Cone Investments Limited Partnership-Sell$4.64M
Oct 21, 2025South Cone Investments Limited Partnership-Sell$11.07M
Dec 13, 2024McKinley Kate Chief Business OfficerBuy$29.99K

Insider Transactions Trends


DateBuySell
2025 Q4-2
2025 Q3--
2025 Q2--
2024 Q422
2024 Q2--

RANI Ownership FAQ


Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 11.03%, followed by 5.90% insiders and 83.07% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 45.24%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Vanguard group (884.61K shares, 2.42%), Nan fung group (493.58K shares, 1.35%), and United services automobile association (302.74K shares, 0.83%). Together, they hold 4.60% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rani Therapeutics.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.62% of its assets in 203.19K Rani Therapeutics shares, valued at 101.55K$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.29% of its total shares outstanding invested in 507.61K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools